TipRanks
XTL Biopharmaceuticals Ltd. Sponsored ADR (DE:HHB0)
FRANKFURT:HHB0
Germany Market
HHB0
XTL Biopharmaceuticals Sponsored ADR
RESEARCH TOOLSreports

XTL Biopharmaceuticals Sponsored ADR (HHB0) Income Statement

0 Followers

XTL Biopharmaceuticals Sponsored ADR Income Statement

Last quarter (Q4 2024), XTL Biopharmaceuticals Sponsored ADR's total revenue was $289.00K, an increase of Infinity% from the same quarter last year. In Q4, XTL Biopharmaceuticals Sponsored ADR's net income was $-255.00K. See XTL Biopharmaceuticals Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 451.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 3.00K$ 0.00$ -1.00K$ -1.00K
Operating Expenses
$ 1.69M$ 2.17M$ 765.00K$ 880.00K$ 1.03M
Depreciation and Amortization
$ 0.00$ 199.00K$ 1.00K$ 1.00K$ 1.00K
EBITDA
$ -752.00K$ -930.00K$ -764.00K$ -879.00K$ -1.03M
Operating Income
$ -1.69M$ -2.17M$ -765.00K$ -880.00K$ -1.03M
Other Income/Expenses
$ 929.00K$ 1.01M$ -1.02M$ -468.00K$ 1.47M
Pretax Income
$ -759.00K$ -1.16M$ -1.78M$ -1.35M$ 435.00K
Net Income
$ -6.97M$ -1.03M$ -1.78K$ -1.35M$ 435.00K
Per Share Metrics
Basic EPS
$ -17.00$ -2.40$ -30.00$ -4.00$ 1.28
Diluted EPS
$ -16.00$ -2.40$ -30.00$ -4.00$ 1.12
Weighted Average Shares Outstanding
 420.65K 420.65K 340.57K 340.57K 332.50K
Weighted Average Shares Outstanding (Diluted)
 440.10K 440.10K 340.57K 340.57K 384.72K
Currency in USD

XTL Biopharmaceuticals Sponsored ADR Earnings and Revenue History